SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-19-014450
Filing Date
2019-03-18
Accepted
2019-03-18 07:07:11
Documents
44
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A tv515406_10qa.htm 10-Q/A 310599
2 EXHIBIT 31.1 tv515406_ex31-1.htm EX-31.1 9493
3 EXHIBIT 31.2 tv515406_ex31-2.htm EX-31.2 9550
4 EXHIBIT 32.1 tv515406_ex32-1.htm EX-32.1 3946
5 EXHIBIT 32.2 tv515406_ex32-2.htm EX-32.2 3993
  Complete submission text file 0001144204-19-014450.txt   2977879

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plx-20180331.xml EX-101.INS 772901
7 XBRL TAXONOMY EXTENSION SCHEMA plx-20180331.xsd EX-101.SCH 24873
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE plx-20180331_cal.xml EX-101.CAL 29789
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plx-20180331_def.xml EX-101.DEF 151536
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE plx-20180331_lab.xml EX-101.LAB 169274
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plx-20180331_pre.xml EX-101.PRE 176096
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-33357 | Film No.: 19686792
SIC: 2836 Biological Products, (No Diagnostic Substances)